PENTACAINE HCL

Penitrocaine is a local anesthetic that blocks voltage-gated sodium channels in nerve membranes, preventing action potential propagation and producing localized numbness. It is used for surface or infiltration anesthesia in minor procedures. Side effects may include transient burning, hypersensitivity, CNS symptoms (tremor, seizures) at high doses, and cardiovascular depression in severe overdose.

SKU: 77fc11ab33c3 Category: Tag:

Product Description


Mechanism of Action

PENTACAINE HCL (ID 27057) demonstrates a multidimensional biochemical activity pattern, affecting enzyme‑regulated catalytic networks, receptor‑mediated intracellular signalling, mitochondrial respiratory pathways, oxidative‑stress regulation, ion‑channel behaviour, cytoskeletal mechanics and transcription‑factor network modulation. Structural evidence suggests potential interactions with catalytic residues, allosteric domains, transmembrane protein complexes, regulatory scaffolds and intracellular signalling intermediates. These interactions allow PENTACAINE HCL to influence phosphorylation kinetics, second‑messenger signalling (Ca²⁺, cAMP, IP₃, DAG), redox‑buffering systems, ATP turnover rates and mitochondrial membrane‑potential stability.

Depending on experimental conditions, PENTACAINE HCL may alter metabolic flux distribution, cytoskeletal tension, vesicular transport efficiency, chromatin‑accessibility patterns and gene‑expression networks related to stress responses, inflammation, apoptosis, autophagy and metabolic adaptation.

Benefits and Advantages

This compound is widely used across high‑resolution biochemical and pharmacological research areas, including:

  • Receptor–ligand interaction analysis and affinity‑mapping
  • Detailed enzyme‑kinetics profiling and catalytic‑pathway evaluation
  • Mitochondrial‑dynamics studies, ATP‑flux modelling and oxidative‑stress research
  • Integrated multi‑omics applications (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membrane‑mechanics modelling
  • Apoptosis, necroptosis, ferroptosis and autophagy signalling pathway studies
  • SAR (structure–activity relationship) and molecular‑optimisation pipelines
  • Mechanistic pharmacodynamic modelling and threshold‑activation experiments

Side Effects and Risks

Laboratory‑observed risks include:

  • Oxidative‑stress imbalance and ROS overproduction
  • Mitochondrial overload or suppression of respiratory‑chain complexes
  • Dysregulation of Na⁺/K⁺/Ca²⁺ transport and ion‑channel behaviour
  • Unintended receptor cross‑talk or inhibitory interference
  • Cytoskeletal destabilisation and membrane‑integrity compromise
  • Dose‑dependent cytotoxicity leading to apoptosis or autophagy
  • Transcriptional instability or inflammatory signalling activation (NF‑κB, JNK, MAPK)

Use exclusively under controlled laboratory conditions with strict biosafety procedures.

Datasheet


Molecular Formula

C17H22N2O3·HCl

Molecular Weight

336.83 g/mol

CAS Number

6108-05-0

Storage Condition

Store at 2-8°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

HMS1361D21

IUPAC/Chemical Name

p-(butoxycarbonyl)phenyl diethylaminoacetate hydrochloride

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download